BIOMARIN PHARMACEUTICAL INC (BMRN) Stock Analyst Earnings Estimates
NASDAQ:BMRN - Nasdaq - US09061G1013 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.096B 13.52% | 2.419B 15.42% | 2.854B 17.97% | 3.167B 10.97% | 3.49B 10.20% | 3.65B 4.58% | 3.916B 7.29% | 4.049B 3.40% | 4.22B 4.22% | 4.148B -1.71% | 4.26B 2.70% | |
| EBITDA YoY % growth | 166.6M 588.43% | 290.16M 74.17% | 666.468M 129.69% | 864.82M 29.76% | 1.118B 29.28% | 1.167B 4.38% | 1.33B 13.97% | 1.475B 10.90% | 1.622B 9.97% | 1.698B 4.69% | 1.713B 0.88% | |
| EBIT YoY % growth | 64.6M 177.09% | 185.774M 187.58% | 570.042M 206.85% | 746.69M 30.99% | 1.007B 34.86% | 1.144B 13.60% | 1.289B 12.67% | 1.431B 11.02% | 1.54B 7.62% | 1.481B -3.83% | 1.5B 1.28% | |
| Operating Margin | 3.08% | 7.68% | 19.97% | 23.58% | 28.85% | 31.34% | 32.92% | 35.34% | 36.49% | 35.70% | 35.21% | |
| EPS YoY % growth | 0.29 180.56% | 0.95 227.59% | 2.21 132.63% | 3.10 40.10% | 4.07 31.38% | 5.69 39.98% | 6.82 19.77% | 7.43 8.98% | 7.71 3.67% | 7.38 -4.26% | 7.83 6.10% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.71 54.12% | 0.77 38.33% | 0.80 46.16% | 0.93 45.24% | 0.77 8.08% | 0.78 0.90% | 0.82 2.36% | 0.93 0.29% |
| Revenue Q2Q % growth | 757.24M 16.71% | 783.52M 10.04% | 810.41M 8.67% | 846.37M 13.26% | 832.34M 9.92% | 847.9M 8.22% | 872.01M 7.60% | 904.87M 6.91% |
| EBITDA Q2Q % growth | 170.67M 61.30% | 182.49M -14.44% | 193.27M -16.06% | 244.15M -8.79% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 163.26M 108.08% | 181.23M 13.64% | 193.42M 22.87% | 226.2M 32.09% | 218.21M 33.66% | 224.36M 23.80% | 241.04M 24.62% | 295.26M 30.53% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 0.64 255.56% | 0.54 | 0.10 | 18.42% |
| Q3 2024 Q2Q % growth | 0.55 161.90% | 0.53 | 0.02 | 4.22% |
| Q2 2024 Q2Q % growth | 0.56 93.10% | 0.36 | 0.20 | 57.23% |
| Q1 2024 Q2Q % growth | 0.46 70.37% | 0.35 | 0.11 | 30.72% |
| Q4 2023 Q2Q % growth | 0.18 | 0.24 | -0.06 | -24.46% |
| Q3 2023 Q2Q % growth | 0.21 625.00% | 0.24 | -0.03 | -12.05% |
| Q2 2023 Q2Q % growth | 0.29 93.33% | 0.24 | 0.05 | 22.09% |
| Q1 2023 Q2Q % growth | 0.27 50.00% | 0.18 | 0.09 | 47.54% |
| Q4 2022 Q2Q % growth | 0.00 100.00% | -0.07 | 0.07 | 100.00% |
| Q3 2022 Q2Q % growth | -0.04 80.00% | -0.01 | -0.03 | -361.36% |
| Q2 2022 Q2Q % growth | 0.15 114.29% | 0.12 | 0.03 | 29.99% |
| Q1 2022 Q2Q % growth | 0.18 100.00% | 0.18 | 0.00 | 2.52% |
| Q4 2021 Q2Q % growth | -0.32 -366.67% | -0.33 | 0.01 | 2.37% |
| Q3 2021 Q2Q % growth | -0.20 -104.99% | -0.25 | 0.05 | 20.94% |
| Q2 2021 Q2Q % growth | 0.07 450.00% | -0.12 | 0.19 | 158.23% |
| Q1 2021 Q2Q % growth | 0.09 -79.55% | -0.07 | 0.16 | 231.05% |
| Q4 2020 Q2Q % growth | 0.12 50.00% | -0.19 | 0.31 | 161.70% |
| Q3 2020 Q2Q % growth | 4.01 1,236.67% | 1.26 | 2.75 | 218.06% |
| Q2 2020 Q2Q % growth | -0.02 90.48% | -0.10 | 0.08 | 79.94% |
| Q1 2020 Q2Q % growth | 0.44 237.50% | 0.05 | 0.39 | 723.70% |
| Q4 2019 Q2Q % growth | 0.08 | -0.06 | 0.14 | 224.77% |
| Q3 2019 Q2Q % growth | 0.30 | 0.06 | 0.24 | 398.93% |
| Q2 2019 Q2Q % growth | -0.21 | -0.12 | -0.09 | -79.03% |
| Q1 2019 Q2Q % growth | -0.32 | -0.19 | -0.13 | -64.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 747.313M 15.65% | 727.71M | 19.603M | 2.69% |
| Q3 2024 Q2Q % growth | 745.74M 28.28% | 714.18M | 31.56M | 4.42% |
| Q2 2024 Q2Q % growth | 712.029M 19.61% | 675.29M | 36.739M | 5.44% |
| Q1 2024 Q2Q % growth | 648.833M 8.79% | 664.82M | -15.987M | -2.40% |
| Q4 2023 Q2Q % growth | 646.207M 20.22% | 649.62M | -3.413M | -0.53% |
| Q3 2023 Q2Q % growth | 581.329M 15.05% | 620.85M | -39.521M | -6.37% |
| Q2 2023 Q2Q % growth | 595.275M 11.52% | 607.14M | -11.865M | -1.95% |
| Q1 2023 Q2Q % growth | 596.415M 14.83% | 582.04M | 14.375M | 2.47% |
| Q4 2022 Q2Q % growth | 537.5M 19.50% | 547.71M | -10.21M | -1.86% |
| Q3 2022 Q2Q % growth | 505.3M 23.64% | 528.78M | -23.48M | -4.44% |
| Q2 2022 Q2Q % growth | 533.8M 6.40% | 531.9M | 1.9M | 0.36% |
| Q1 2022 Q2Q % growth | 519.4M 6.87% | 517.67M | 1.73M | 0.33% |
| Q4 2021 Q2Q % growth | 449.8M -0.51% | 451.23M | -1.43M | -0.32% |
| Q3 2021 Q2Q % growth | 408.7M -14.28% | 444.03M | -35.33M | -7.96% |
| Q2 2021 Q2Q % growth | 501.7M 16.81% | 457.47M | 44.23M | 9.67% |
| Q1 2021 Q2Q % growth | 486M -3.21% | 455.38M | 30.62M | 6.72% |
| Q4 2020 Q2Q % growth | 452.1M -0.51% | 449.03M | 3.07M | 0.68% |
| Q3 2020 Q2Q % growth | 476.8M 3.40% | 463.74M | 13.06M | 2.82% |
| Q2 2020 Q2Q % growth | 429.5M 10.75% | 426.99M | 2.51M | 0.59% |
| Q1 2020 Q2Q % growth | 502.1M 25.31% | 478.15M | 23.95M | 5.01% |
| Q4 2019 Q2Q % growth | 454.4M | 468.52M | -14.12M | -3.01% |
| Q3 2019 Q2Q % growth | 461.1M | 463.64M | -2.54M | -0.55% |
| Q2 2019 Q2Q % growth | 387.8M | 423.34M | -35.54M | -8.40% |
| Q1 2019 Q2Q % growth | 400.7M | 397.45M | 3.25M | 0.82% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 10.15% | 12.11% | 0% | 1.45% |
| Revenue | 1.52% | 2.12% | -0.03% | 0.22% |